Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center studyJonas Willmann, Nicolaus Andratschke, Eugenia Vlaskou Badra et al.|Radiotherapy and Oncology|2022Cited by 46
Measuring Global Inequity in Radiation Therapy: Resource Deficits in Low- and Middle-Income Countries Without Radiation Therapy FacilitiesSebastian M. Christ, Jonas Willmann|Advances in Radiation Oncology|2023Cited by 29
Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional StudySebastian M. Christ, Matthias Gückenberger, Stephanie Kroeze et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 28
Distant Metastasis Velocity as a Novel Prognostic Score for Overall Survival After Disease Progression Following Stereotactic Body Radiation Therapy for Oligometastatic DiseaseJonas Willmann, Nicolaus Andratschke, Eugenia Vlaskou Badra et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 18
Potential of ChatGPT in facilitating research in radiation oncology?Matthias Gückenberger, Michael Mayinger, Nicolaus Andratschke et al.|Radiotherapy and Oncology|2023Cited by 14